ÂÜÀòÂÒÂ×

Linda Price holds extensive experience in market access and oncology, currently serving as Senior Director at Incyte since April 2021, where responsibilities include developing payer strategy for Opzelura in Vitiligo and creating comprehensive payer marketing resources. Previously at AstraZeneca from January 2014 to April 2021, Linda advanced through several roles, including Contract Strategy Director for oncology, focusing on health system contract strategies and portfolio growth. Prior roles at MedImmune and Meda Pharmaceuticals provided foundational skills in sales training, account management, and strategic marketing. Linda Price holds an MBA in Marketing Management from Goldey-Beacom College and a BS in Pharmaceutical Marketing from Saint Joseph's University.